In human colon cancer cell models, silibinin was also able to enhance the expression (protein and mRNA) of TRAIL death receptors (DR4/DR5) at the cell surface in colon cancer SW480 cells and to induce their expression in TRAIL-resistant SW620 cells normally not expressing DR4/DR5. This evidence concerns the gene TNFRSF10B and colonic neoplasm.